These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12142384)

  • 21. Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
    Leewansangtong S; Goktas S; Lepoff R; Holthaus K; Crawford ED
    Urology; 1998 Sep; 52(3):467-9. PubMed ID: 9730462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method comparison studies for prostate specific antigen and unconjugated estriol immunoassays.
    Koenn ME; Ndah BV
    Clin Lab Sci; 2003; 16(2):94-8. PubMed ID: 12757188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Abbott IMx automated immunoassay of prostate-specific antigen.
    Vessella RL; Noteboom J; Lange PH
    Clin Chem; 1992 Oct; 38(10):2044-54. PubMed ID: 1382897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Point-of-care fluorescence immunoassay for prostate specific antigen.
    Oh SW; Kim YM; Kim HJ; Kim SJ; Cho JS; Choi EY
    Clin Chim Acta; 2009 Aug; 406(1-2):18-22. PubMed ID: 19393638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of polyclonal serum prostate specific antigen levels in screening for prostate cancer: a comparison with corresponding monoclonal values.
    Terris MK; Stamey TA
    Br J Urol; 1994 Jan; 73(1):61-4. PubMed ID: 7507783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist.
    Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J
    Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen.
    Semjonow A; Oberpenning F; Brandt B; Zechel C; Brandau W; Hertle L
    Urology; 1996 Dec; 48(6A Suppl):10-5. PubMed ID: 8973694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen.
    Sokoll LJ; Bruzek DJ; Dua R; Dunn W; Mohr P; Wallerson G; Eisenberger M; Partin AW; Chan DW
    Urology; 2002 Oct; 60(4 Suppl 1):24-30. PubMed ID: 12384159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patients.
    Douglas TH; Morgan TO; McLeod DG; Moul JW; Murphy GP; Barren R; Sesterhenn IA; Mostofi FK
    Cancer; 1997 Jul; 80(1):107-14. PubMed ID: 9210715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].
    Irani J; Millet C; Levillain P; Doré B; Bégon F; Aubert J
    Chirurgie; 1997; 122(8-9):478-82. PubMed ID: 9616891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group.
    Schambeck CM
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.
    Igawa T; Takehara K; Onita T; Ito K; Sakai H
    J Clin Lab Anal; 2014 Jul; 28(4):315-9. PubMed ID: 24578247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population.
    Komatsu K; Wehner N; Prestigiacomo AF; Chen Z; Stamey TA
    Urology; 1996 Mar; 47(3):343-6. PubMed ID: 8633399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen.
    Lechevallier E; Eghazarian C; Ortega JC; Roux F; Coulange C
    Urology; 1999 Nov; 54(5):857-61. PubMed ID: 10565747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with an assay for prostate-specific antigen and transrectal ultrasonography in the diagnosis of prostate cancer.
    Heman-Ackah CA; Festenstein JB; Hibbert P; Harvey DJ; Bunce CJ; Gelister JS
    Br J Urol; 1997 Mar; 79(3):439-44. PubMed ID: 9117228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measurement of complexed PSA improves specificity for early detection of prostate cancer.
    Brawer MK; Meyer GE; Letran JL; Bankson DD; Morris DL; Yeung KK; Allard WJ
    Urology; 1998 Sep; 52(3):372-8. PubMed ID: 9730446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
    Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E
    J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CLSI EP17-A protocol: a useful tool for better understanding the low end performance of total prostate-specific antigen assays.
    Moretti M; Sisti D; Rocchi MB; Delprete E
    Clin Chim Acta; 2011 May; 412(11-12):1143-5. PubMed ID: 21396930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleic acid detection immunoassay for prostate-specific antigen based on immuno-PCR methodology.
    McDermed JE; Sanders R; Fait S; Klem RE; Sarno MJ; Adams TH; Diamandis EP
    Clin Chem; 2012 Apr; 58(4):732-40. PubMed ID: 22361936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.